Summary:
- The article discusses the proposed overhaul of the U.S. vaccine approval process, which aims to streamline the review and approval of new vaccines.
- The changes include allowing the FDA to use real-world data and evidence, rather than relying solely on clinical trials, to evaluate vaccine safety and efficacy.
- This shift towards a more flexible and adaptive approach to vaccine approval is expected to have significant implications for the future of vaccine development and public health.